Case Letter

Fingernail Photo-onycholysis After Aminolevulinic Acid–Photodynamic Therapy Under Blue Light for Treatment of Actinic Keratoses on the Face

Author and Disclosure Information

 

References

A 65-year-old woman was treated for AKs on the perioral region of the face with PDT. Aminolevulinic acid hydrochloride 20% was applied to the lips and allowed to incubate for 60 minutes. Her face was illuminated with 10 J/cm² of blue light (417 nm) for 16 minutes and 40 seconds. Sunscreen (sun protection factor 40) was applied to the area immediately after treatment, and the patient was thoroughly counseled to avoid sunlight for the next 48 hours and to use sun protection. Within 72 hours following treatment, the patient reported all 10 fingernails noticeably separated from the nail bed with minimal pain, corresponding to type I photo-onycholysis (Figure). The patient’s only medications were vitamin D (1000 mg once daily) and calcium supplements (1500 mg twice daily). Although the patient exercised strict UV light avoidance for the face, her hands were not protected when she went gardening directly after the treatment. At 5 weeks, the patient returned for her second ALA-PDT treatment of perioral AK and a fungal culture was taken of the left third fingernail, which returned negative results. Poly-ureaurethane nail lacquer 16% was prescribed and was used once daily to protect and strengthen the fingernails. The patient returned for follow-up in clinic after 13 weeks and photo-onycholysis was resolving. Photo-onycholysis is categorized as a phototoxic reaction often associated with drug intake, more specifically with the use of tetracyclines, psoralens, and fluoroquinolones; less commonly with oral contraceptives; or spontaneously.6 It usually is recognized as a crescent-shaped distal separation of the nail surrounded by pigment. The action spectrum is believed to include UVA and UVB, though the exact mechanisms have not been confirmed.5

Photo-onycholysis of the fingernails induced by aminolevulinic acid–photodynamic therapy 72 hours following treatment.

Our case provides evidence for risks involving the development of photo-onycholysis following PDT. We have no reason to believe there was systemic absorption of ALA, as there were no visible vesicles on the arms or hands after the treatment. Negative fungal culture results excluded onychomycosis. It is our hypothesis that the patient touched her face with her fingernails during the 60-minute incubation time prior to ALA-PDT treatment under blue light, inadvertently collecting ALA under the fingernails. Once she exposed her hands to sunlight while gardening after treatment, the nails likely reacted with the ALA in response to the UV radiation, thus triggering photo-onycholysis.

This case represents a report of fingernail photo-onycholysis from ALA-PDT under blue light as well as a report following treatment of AK not located on the hands with PDT. Although the photo-onycholysis did resolve within a few months of treatment, our case demonstrates the importance of counseling patients more specifically about isolating the ALA treatment zone from nontreated areas on the body during incubation. Improper UV light protection following ALA-PDT is known to produce phototoxic reactions and our case supports this outcome.

Pages

Recommended Reading

Toe Nodule Obliterating the Nail Bed
MDedge Dermatology
Onychomadesis Following Hand-foot-and-mouth Disease
MDedge Dermatology
Spontaneous Repigmentation of Silvery Hair in an Infant With Congenital Hydrops Fetalis and Hypoproteinemia
MDedge Dermatology
Skin Lesions in Patients Treated With Imatinib Mesylate: A 5-Year Prospective Study
MDedge Dermatology
JAK inhibitor improves alopecia, with caveats
MDedge Dermatology
Keys to alopecia areata might lie in gut microbiome
MDedge Dermatology
VIDEO: The ins and outs of JAK ihibitors for alopecia
MDedge Dermatology
Clinical Characteristics and HLA Alleles of a Family With Simultaneously Occurring Alopecia Areata
MDedge Dermatology
Patch of Hair Loss on the Scalp
MDedge Dermatology
Studies highlight diagnostic and treatment challenges in hidradenitis suppurativa
MDedge Dermatology